Skip to main content
Erschienen in: Indian Journal of Surgical Oncology 1/2019

16.10.2018 | Original Article

Rate of Breast-Conserving Surgery vs Mastectomy in Breast Cancer: a Tertiary Care Centre Experience from South India

verfasst von: Shaziya Hassan Ali, Somashekhar S.P, Arun Kumar N

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Worldwide, breast conservation has become increasingly accepted as the surgical management of breast cancer in clinical practice. Cancer care in India is also evolving tremendously with many cancer treatment centres following evidence-based practice hence the rates of breast conservation are expected to increase. Here, we are reporting the rate of breast-conserving surgery (BCS) at our centre. A retrospective study of 401 patients who underwent breast cancer surgery at a tertiary care centre in South India from January 2015 to August 2017 were analysed to study the rate of BCS. All early breast cancers (EBC) were offered BCS. For large operable breast cancer (LOBC) and locally advanced breast cancer (LABC), neoadjuvant chemotherapy (NACT) followed by BCS was offered to these patients who wish to conserve their breast. The mean age was 45 years. A total of 163 patients underwent BCS. Yearly, BCS rates were 38.8% in 2015, 36.7% in 2016 and 46.5% in 2017. Majority had EBC 310 (77.3%) of which 62.7% of T1 lesions (n = 51) had BCS, and 45.7% of T2 lesions (n = 258) had BCS of which 5 patients had to undergo NACT to preserve their breast whereas 100% Tis patient (n = 1) had mastectomy. Fifty patients had LOBC and only 2 (4%) patients had upfront BCS whereas 9 of them had to undergo NACT (18%). cT4 lesions had NACT followed by BCS in 2 patients. The rates of BCS have been increasing in India over the past few years. The majority of the women presented with EBC which makes them suitable for BCS.
Literatur
1.
Zurück zum Zitat Asthana S, Chauhan S, Labani S (2014) Breast and cervical cancer risk in India: an update. Indian J Public Health 58:5–10CrossRefPubMed Asthana S, Chauhan S, Labani S (2014) Breast and cervical cancer risk in India: an update. Indian J Public Health 58:5–10CrossRefPubMed
2.
Zurück zum Zitat Khokhar A (2012) Breast cancer in India: where do we stand and where do we go? Asian Pac J Cancer Prev 13:4861–4866CrossRefPubMed Khokhar A (2012) Breast cancer in India: where do we stand and where do we go? Asian Pac J Cancer Prev 13:4861–4866CrossRefPubMed
3.
Zurück zum Zitat Keynes G (1928) Radium treatment of primary carcinoma of the breast. Lancet 2:108CrossRef Keynes G (1928) Radium treatment of primary carcinoma of the breast. Lancet 2:108CrossRef
4.
Zurück zum Zitat Lichter AS, Lippman ME, Danforth DN Jr, d’Angelo T, Steinberg SM, deMoss E, MacDonald HD, Reichert CM, Merino M, Swain SM et al (1992) Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 10:976–983CrossRef Lichter AS, Lippman ME, Danforth DN Jr, d’Angelo T, Steinberg SM, deMoss E, MacDonald HD, Reichert CM, Merino M, Swain SM et al (1992) Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 10:976–983CrossRef
5.
Zurück zum Zitat Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D et al (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143–1150CrossRefPubMed Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D et al (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143–1150CrossRefPubMed
6.
Zurück zum Zitat Foster RS, Farwell ME, Costanza MC (1995) Breast-conserving care for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 2:275–280CrossRefPubMed Foster RS, Farwell ME, Costanza MC (1995) Breast-conserving care for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 2:275–280CrossRefPubMed
7.
Zurück zum Zitat Morrow M, Bucci C, Rademaker A (1998) Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 186:269–274CrossRefPubMed Morrow M, Bucci C, Rademaker A (1998) Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 186:269–274CrossRefPubMed
8.
Zurück zum Zitat Martin MA, Meyricke R, O’Neill T et al (2006) Mastectomy or breast conserving surgery? Factors affecting type of surgical treatment for breast cancer: a classification tree approach. BMC Cancer 6:98CrossRefPubMedPubMedCentral Martin MA, Meyricke R, O’Neill T et al (2006) Mastectomy or breast conserving surgery? Factors affecting type of surgical treatment for breast cancer: a classification tree approach. BMC Cancer 6:98CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major centre in North India. Indian J Cancer 42:36–41 Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major centre in North India. Indian J Cancer 42:36–41
10.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
11.
Zurück zum Zitat Babu GR, Lakshmi SB, Thiyagarajan JA (2013) Epidemiological correlates of breast cancer in South India. Asian Pac J Cancer Prev 14:5077–5083CrossRefPubMed Babu GR, Lakshmi SB, Thiyagarajan JA (2013) Epidemiological correlates of breast cancer in South India. Asian Pac J Cancer Prev 14:5077–5083CrossRefPubMed
12.
Zurück zum Zitat Ali I, Wani WA, Saleem K (2011) Cancer scenario in India with future perspectives. Cancer Ther 8:56–70 Ali I, Wani WA, Saleem K (2011) Cancer scenario in India with future perspectives. Cancer Ther 8:56–70
13.
Zurück zum Zitat Rangarajan, Bharath et al. Breast cancer: an overview of published Indian data. South Asian J Cancer 2016. 5.3: 86–92 Rangarajan, Bharath et al. Breast cancer: an overview of published Indian data. South Asian J Cancer 2016. 5.3: 86–92
14.
Zurück zum Zitat Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A (2014) Age shift: breast cancer is occurring in younger age groups—is it true? Clin Cancer Investig J 3:526–529CrossRef Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A (2014) Age shift: breast cancer is occurring in younger age groups—is it true? Clin Cancer Investig J 3:526–529CrossRef
15.
Zurück zum Zitat Narendra H, Ray S (2011) Breast surgery for breast cancer: single institutional experience from Southern India. Indian J Cancer 48:415–422CrossRefPubMed Narendra H, Ray S (2011) Breast surgery for breast cancer: single institutional experience from Southern India. Indian J Cancer 48:415–422CrossRefPubMed
16.
Zurück zum Zitat Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L (1989) Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822–828CrossRefPubMed Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L (1989) Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822–828CrossRefPubMed
17.
Zurück zum Zitat Dinshaw KA, Budrukkar AN, Chinoy RF, Sarin R, Badwe R, Hawaldar R, Shrivastava SK (2005) Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 63:1132–1141CrossRefPubMed Dinshaw KA, Budrukkar AN, Chinoy RF, Sarin R, Badwe R, Hawaldar R, Shrivastava SK (2005) Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 63:1132–1141CrossRefPubMed
18.
Zurück zum Zitat Aziz Z, Sana S, Akram M, Saeed A (2004) Socioeconomic status and breast cancer survival in Pakistani women. J Pak Med Assoc 54:448–453PubMed Aziz Z, Sana S, Akram M, Saeed A (2004) Socioeconomic status and breast cancer survival in Pakistani women. J Pak Med Assoc 54:448–453PubMed
19.
Zurück zum Zitat Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK, Mohanti BK, Rath GK (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed Raina V, Bhutani M, Bedi R, Sharma A, Deo SV, Shukla NK, Mohanti BK, Rath GK (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45CrossRefPubMed
20.
Zurück zum Zitat Tewari M, Pradhan S, Kumar M, Shukla HS (2006) Effect of prevailing local treatment options of breast cancer on survival outside controlled clinical trials: experience of a specialist breast unit in North India. World J Surg 30:1794–1801CrossRefPubMed Tewari M, Pradhan S, Kumar M, Shukla HS (2006) Effect of prevailing local treatment options of breast cancer on survival outside controlled clinical trials: experience of a specialist breast unit in North India. World J Surg 30:1794–1801CrossRefPubMed
21.
Zurück zum Zitat Hage JA, Velde CJ, Julien JP, Hulin MT, Vandervelden C, Duchateau L (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19:4224–4237CrossRefPubMed Hage JA, Velde CJ, Julien JP, Hulin MT, Vandervelden C, Duchateau L (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19:4224–4237CrossRefPubMed
22.
Zurück zum Zitat Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni MS, Sarin R, Chinoy R, Nair R, Dinshaw KA, Badwe RA (2006) Breast conservation treatment in women with locally advanced breast cancer – experience from a single centre. Int J Surg 4:106–114CrossRefPubMed Parmar V, Krishnamurthy A, Hawaldar R, Nadkarni MS, Sarin R, Chinoy R, Nair R, Dinshaw KA, Badwe RA (2006) Breast conservation treatment in women with locally advanced breast cancer – experience from a single centre. Int J Surg 4:106–114CrossRefPubMed
23.
Zurück zum Zitat Aggarwal V, Agarwal G, Lal P, Krishnani N, Mishra A, Verma AK, Mishra SK (2007, Nov 21) Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg Aggarwal V, Agarwal G, Lal P, Krishnani N, Mishra A, Verma AK, Mishra SK (2007, Nov 21) Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg
24.
Zurück zum Zitat Baron LF, Baron PL, Ackerman SJ, Durden DD, Pope TL (2000) Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 174:539–540CrossRefPubMed Baron LF, Baron PL, Ackerman SJ, Durden DD, Pope TL (2000) Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 174:539–540CrossRefPubMed
25.
Zurück zum Zitat Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF (2000) Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 9:267–270CrossRefPubMed Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF (2000) Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 9:267–270CrossRefPubMed
26.
Zurück zum Zitat Jia H, Jia W, Yang Y, Li S, Feng H, Liu J, Rao N, Jin L, Wu J, Gu R, Zhu L, Chen K, Deng H, Zeng Y, Liu Q, Song E, Su F (2014) HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World J Surg Oncol 12:289CrossRefPubMedPubMedCentral Jia H, Jia W, Yang Y, Li S, Feng H, Liu J, Rao N, Jin L, Wu J, Gu R, Zhu L, Chen K, Deng H, Zeng Y, Liu Q, Song E, Su F (2014) HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World J Surg Oncol 12:289CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Morrow M (2013) Personalizing extent of breast cancer surgery according to molecular subtypes. Breast 22(Suppl 2):S106–S109CrossRefPubMed Morrow M (2013) Personalizing extent of breast cancer surgery according to molecular subtypes. Breast 22(Suppl 2):S106–S109CrossRefPubMed
28.
Zurück zum Zitat Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L, Cancer and Leukemia Group B, Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977CrossRef Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, Wheeler J, Champion LA, Smith TJ, Smith BL, Shapiro C, Muss HB, Winer E, Hudis C, Wood W, Sugarbaker D, Henderson IC, Norton L, Cancer and Leukemia Group B, Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–977CrossRef
Metadaten
Titel
Rate of Breast-Conserving Surgery vs Mastectomy in Breast Cancer: a Tertiary Care Centre Experience from South India
verfasst von
Shaziya Hassan Ali
Somashekhar S.P
Arun Kumar N
Publikationsdatum
16.10.2018
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2019
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0818-7

Weitere Artikel der Ausgabe 1/2019

Indian Journal of Surgical Oncology 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.